Targeting Antisense lncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells

Frontiers in Medicine

Yong Deng¹  Hong Wang¹  Yanjiao Ou¹  Qingyi Zhang¹  Huan Luo¹  Peng Hu² 

[1] Department of Hepatobiliary Surgery, The First Affiliated Hospital of Army Medical University, Chongqing, China;null;

关键词: PRKAG2-AS1;    hepatocellular carcinoma;    therapeutic target;    proliferation;    migration;    invasion;   

DOI  :  10.3389/fmed.2021.649279

来源: Frontiers

【 授权许可】

CC BY